Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group Study

PURPOSE: Intraperitoneal chemotherapy has shown a survival advantage over intravenous chemotherapy for women with newly diagnosed optimally debulked epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. However, significant toxicity has limited its acceptance. In an effort to reduce t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Dizon, Don S., Sill, Michael W., Gould, Natalie, Rubin, Stephen C., Yamada, S. Diane, DeBernardo, Robert L., Mannel, Robert S., Eisenhauer, Eric L., Duska, Linda R., Fracasso, Paula M.
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3201726/
https://ncbi.nlm.nih.gov/pubmed/21820161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.07.016
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars